Lignins and Lignans Recent Developments and Trends Regarding their Pharmaceutical Properties
- Authors: Luc Zongo1, Heiko Lange2
-
View Affiliations Hide Affiliations1 Department of Pharmacy, University of Saint Dominic of West Africa (USDAO), Doulougou, Burkina Faso 2 Department of Environmental and Earth Sciences, University of Milano Bicocca, Milan, Italy
- Source: Flavonoids and Phenolics , pp 196-248
- Publication Date: November 2022
- Language: English
Lignins and Lignans Recent Developments and Trends Regarding their Pharmaceutical Properties, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789815079098/chapter-7-1.gif
Lignins and lignans as natural polyphenols exhibit a rather broad variety of common physico-chemical features that can be of interest with respect to their use in the pharmaceutical sector. While polyphenol types have antioxidant, antiinflammatory, antibacterial and eventually antiviral activities in common, structural features beyond the polyphenol aspect differ enormously: isolated lignins are oligomers and/or polymers of monolignol C9-building blocks, while lignans are based on dimers thereof. The structural differences caused lignin to be exploited in the pharmaceutical sector mainly as material for the generation of matrices and carrier for drug delivery, while lignans are tested for the suitability as APIs. The chapter gives an overview of this situation, including the biological backgrounds of the two interesting natural polyphenols, isolation and methods for their characterisation.
-
From This Site
/content/books/9789815079098.chapter-7dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
